| Product Code: ETC9690850 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Oncology-Cancer Drugs Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Oncology-Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Oncology-Cancer Drugs Market - Industry Life Cycle |
3.4 Thailand Oncology-Cancer Drugs Market - Porter's Five Forces |
3.5 Thailand Oncology-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Thailand Oncology-Cancer Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Thailand Oncology-Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Thailand |
4.2.2 Rising healthcare expenditure and government initiatives to improve cancer care |
4.2.3 Advancements in oncology research and development of new cancer drugs |
4.2.4 Growing awareness about early cancer detection and treatment options |
4.3 Market Restraints |
4.3.1 High cost of oncology-cancer drugs |
4.3.2 Stringent regulatory requirements for drug approval |
4.3.3 Limited access to specialized cancer care facilities in remote areas |
4.3.4 Competition from generic drug manufacturers |
5 Thailand Oncology-Cancer Drugs Market Trends |
6 Thailand Oncology-Cancer Drugs Market, By Types |
6.1 Thailand Oncology-Cancer Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Thailand Oncology-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Thailand Oncology-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 Thailand Oncology-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 Thailand Oncology-Cancer Drugs Market Revenues & Volume, By Immunotherapy (Biologic Therapy), 2021- 2031F |
6.1.6 Thailand Oncology-Cancer Drugs Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.2 Thailand Oncology-Cancer Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Thailand Oncology-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.3 Thailand Oncology-Cancer Drugs Market Revenues & Volume, By Stomach Cancer, 2021- 2031F |
6.2.4 Thailand Oncology-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.5 Thailand Oncology-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.6 Thailand Oncology-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.7 Thailand Oncology-Cancer Drugs Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.8 Thailand Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
6.2.9 Thailand Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
7 Thailand Oncology-Cancer Drugs Market Import-Export Trade Statistics |
7.1 Thailand Oncology-Cancer Drugs Market Export to Major Countries |
7.2 Thailand Oncology-Cancer Drugs Market Imports from Major Countries |
8 Thailand Oncology-Cancer Drugs Market Key Performance Indicators |
8.1 Number of new cancer cases diagnosed annually in Thailand |
8.2 Adoption rate of innovative cancer therapies in the market |
8.3 Investment in oncology research and development |
8.4 Patient survival rates for different types of cancer in Thailand |
8.5 Number of oncology clinical trials conducted in the country |
9 Thailand Oncology-Cancer Drugs Market - Opportunity Assessment |
9.1 Thailand Oncology-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Thailand Oncology-Cancer Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Thailand Oncology-Cancer Drugs Market - Competitive Landscape |
10.1 Thailand Oncology-Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 Thailand Oncology-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here